TRIB

Trinity Biotech plc (NASDAQ:TRIB) is an Irish medical diagnostics company founded in 1992 and headquartered in Bray, Ireland. The company has been publicly traded since its IPO in October 1992. Trinity Biotech operates as a global manufacturer and distributor of medical diagnostic products, serving clinical laboratories and point-of-care testing markets across the Americas, Africa, Asia, and Europe. The company has undergone significant strategic transformation in recent years, pivoting from COVID-related testing revenues toward growth areas including HIV rapid testing, diabetes monitoring, and next-generation continuous glucose monitoring technology.